One-fifth of the patients (20%) had previously been diagnosed with cerebral palsy (CP), mostly among the UBE3A mutation group, which may be due to the mildest clinical presentation of patients with this genetic background [4, 5, 21]. This evidence concerns the gene UBE3A and cerebral palsy.